GL1X · GenesisL1 explorer

Research workbench

Human dihydroorotate dehydrogenase in complex with a leflunomide derivative inhibitor 5

Analyse Human dihydroorotate dehydrogenase in complex with a leflunomide derivative… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3G0X
Type
protein
Length
360 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Dihydroorotate dehydrogenase
EC
1.3.3.1
UniProt
Q02127
Ligands
FMN, ORO, MD7, SO4
Pockets
4 · best druggability 0.83

Structure

x-ray diffraction · 1 distinct chain · 47% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADihydroorotate dehydrogenase (EC 1.3.3.1)protein36047% helix, 16% strandQ02127

Ligands and binding sites

  • FMN · Flavin mononucleotide · ligand · chains A
  • ORO · Orotic acid · ligand · chains A
  • MD7 · (2Z)-N-biphenyl-4-yl-2-cyano-3-cyclopropyl-3-hydroxyprop-2-enamide · ligand · chains A
  • SO4 · Sulfate ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13920.830.9156FMN, ORO, MD7
2810.410.7918empty
3910.380.7718empty
4540.280.7411empty

Compared structures

  • 3G0X · Human dihydroorotate dehydrogenase in complex with a leflunomide derivative inhibitor 5 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.